Analysts at HC Wainwright upped their price objective on shares of Insmed Incorporated (NASDAQ:INSM) from $25.00 to $30.00 in a research report issued to clients and investors on Wednesday, Stock Ratings Network.com reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 63.93% from the stock’s previous close.Insmed Incorporated (NASDAQ:INSM) shares after opening at $16.00 moved to $17.38 on last trade day and at the end of the day closed at $15.90. Company price to sales ratio in past twelve months was calculated as 54.20 and price to cash ratio as 5.47. Insmed Incorporated (NASDAQ:INSM) showed a negative weekly performance of -15.94%.
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) looks like it has exhausted its energy to rally upwards. The slow adoption of fuel-cells technology and lack of significant business coming to it do not come across as positive news to keep investors eager to buy. Thus, the stock can be seen facing south. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) shares fell -22.78% in last trading session and ended the day on $4.17. BLDP return on equity ratio is recorded as -57.70% and its return on assets is -28.60%. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) yearly performance is 317.00%.
Exelixis, Inc. (NASDAQ:EXEL)’s prostate cancer drug candidate which showed positive results in the Phase II of clinical trial will not come to the market soon. The company announced Tuesday that an independent monitoring committee has recommended that it continues with the Phase III study of the drug. Exelixis, Inc. (NASDAQ:EXEL) shares moved down -39.36% in last trading session and was closed at $3.90, while trading in range of $3.87-$4.50. Exelixis, Inc. (NASDAQ:EXEL) year to date performance is -36.30%.
The Arotech Corporation (NASDAQ:ARTX) on Mar. 24 announced that its Battery and Power Systems Division has received orders amounting to over $2 million for batteries and chargers. The orders were primarily from two leading defense companies and manufacturers of military equipment, which are existing customers of Arotech. One of the orders was for the development and manufacture of Lithium-Ion based batteries as replacements for Lead-Acid batteries for use in military vehicles. Arotech’s Lithium-Ion batteries together with its battery management technologies, provides a much higher energy density than similarly sized Lead-Acid batteries, with a high safety profile as well as low maintenance requirements. Arotech Corporation (NASDAQ:ARTX) weekly performance is 17.19%. On last trading day company shares ended up $5.25. Arotech Corporation (NASDAQ:ARTX) distance from 50-day simple moving average is 52.82%. Analysts mean target price for the company is $5.00.